Delivery Order SPE2DB20D1047-SPE2DB24FF81S
Award Date
8/2/24
Potential Completion Date
8/23/24
Potential Value
$6.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of PROQUAD VIALS. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $3,141.08. The contract has an Ultimate Completion Date of September 24, 2024 and was awarded on September 3, 2024. This award is not associated with a set-aside program and is considered a Child contract. AmerisourceBergen,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $12,789.80 firm-fixed price delivery order is for the supply of PROQUAD VIALS, a pharmaceutical product. The contract has an ultimate completion date of October 4, 2024. AmerisourceBergen, a for-profit organization, is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities and...
This federal contract award is for the delivery of PROQUAD VIALS medical products to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp's Corporate Office division. The contract has a ceiling value of $9,611.94 and is a Firm Fixed Price Delivery Order. Amerisourcebergen, a major pharmaceutical distribution company, holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 2025 to provide a comprehensive range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,740.49 firm-fixed-price delivery order is for the procurement of 4,568,032,234 PROQUAD VIALS. The contract has an ultimate completion date of May 13, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $1,570.54, has a completion date of July 31, 2024. The contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC enables the DLA to...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), an alternate name for which is the Defense Logistics Agency. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $4,962.99, for the delivery of PROQUAD VIALS. The contract has an ultimate completion date of June 27, 2025 and was awarded on June 5, 2025. The contract is not designated as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PROQUAD VIALS. The $3,203.98 Firm Fixed Price Delivery Order has an ultimate completion date of August 20, 2024. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a range of medical commodities to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,575.60 firm fixed price delivery order is for the supply of PROQUAD VIALS, a pharmaceutical product. The contract has a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of PROQUAD VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical under a Firm Fixed Price Delivery Order contract. The award has a ceiling value of $3,141.08 and an ultimate completion date of July 1, 2024. This contract is not associated with a set-aside designation. As a major pharmaceutical distributor, Amerisourcebergen leverages its...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) for the delivery of PROQUAD VIALS, a medical product. The $1,670.90 firm fixed price delivery order has an ultimate completion date of April 22, 2025 and does not utilize a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...